A Common Variant of IL-6R is Associated with Elevated IL-6 Pathway Activity in Alzheimer's Disease Brains.
A Common Variant of IL-6R is Associated with Elevated IL-6 Pathway Activity in Alzheimer's Disease Brains.
复制标题
DOI:
10.3233/jad-160524
复制
发表时间:
2017
期刊:
影响因子:
--
通讯作者:
van der Brug M
中科院分区:
文献类型:
--
作者:
Haddick PC;Larson JL;Rathore N;Bhangale TR;Phung QT;Srinivasan K;Hansen DV;Lill JR;Alzheimer’s Disease Genetic Consortium (ADGC), Alzheimer’s Disease Neuroimaging Initiative (ADNI);Pericak-Vance MA;Haines J;Farrer LA;Kauwe JS;Schellenberg GD;Cruchaga C;Goate AM;Behrens TW;Watts RJ;Graham RR;Kaminker JS;van der Brug M
The common p.D358A variant (rs2228145) in IL-6R is associated with risk for multiple diseases and with increased levels of soluble IL-6R in the periphery and central nervous system (CNS). Here, we show that the p.D358A allele leads to increased proteolysis of membrane bound IL-6R and demonstrate that IL-6R peptides with A358 are more susceptible to cleavage by ADAM10 and ADAM17. IL-6 responsive genes were identified in primary astrocytes and microglia and an IL-6 gene signature was increased in the CNS of late onset Alzheimer’s disease subjects in an IL6R allele dependent manner. We conducted a screen to identify variants associated with the age of AD onset in APOE ε4 carriers. Across 5 datasets, p.D358A had a meta P=3×10−4 and an odds ratio (OR) = 1.3, 95% confidence interval (CI) 1.12 – 1.48. Our study suggests that a common coding region variant of the IL-6 receptor results in neuroinflammatory changes that may influence the age of onset in AD in APOE ε4 carriers.